封面
市場調查報告書
商品編碼
1485278

疤痕治療市場- 副產品(外用[乳膏、凝膠]、雷射[CO2、脈衝染色]、注射)、類型(萎縮性、攣縮性、肥厚性和蟹足腫、妊娠紋)、最終用途(醫院、診所、零售)藥局) - 全球預測 2024 - 2032

Scar Treatment Market - By Product (Topical [Cream, Gel], Laser [CO2, Pulse-dyed], Injectables), Type (Atrophic, Contracture, Hypertrophic & Keloid Scars, Stretch Marks), End-use (Hospitals, Clinics, Retail Pharmacies) - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 178 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於燒傷、手術和創傷病例發生率上升,預計 2024 年至 2032 年疤痕治療市場規模將以超過 9.6% 的複合年成長率擴大。雷射療法和矽膠片等技術的巨大進步提供了更有效和微創的治療選擇,從而加速了疤痕治療解決方案的吸引力。

由於人們越來越重視美觀和對完美肌膚的渴望,消費者對疤痕治療產品和手術的可用性的認知不斷提高,推動了對多種治療技術的偏好。優惠報銷政策的推出和醫療基礎設施的發展也推動了疤痕治療療法的採用

化妝品領域的巨額研發投資進一步促進了新配方的開發,促進了市場成長。例如,2023 年 8 月,護膚品牌 Topicals 推出了 Sealed Active Scar Primer。該產品在化妝前填充痤瘡疤痕,並逐漸增強膚質。

疤痕治療產業分為產品、類型、最終用途和地區。

從產品來看,預計2024年至2032年雷射產品領域的市場規模將達到9.6%的複合年成長率。的治療。點陣雷射系統等雷射技術的發展正在提高治療效果並最大限度地減少停機時間。消費者對非侵入性和痛苦最小的疤痕治療方案的日益偏好也將刺激對雷射產品的需求。

根據類型,妊娠紋領域的疤痕治療市場預計從 2024 年到 2032 年將以 9.2% 的成長率擴張。除了人們對妊娠紋治療的認知和接受度不斷提高之外,專為妊娠紋設計的外用乳膏、油和雷射療法的可用性不斷增加,也加速了產品的滲透。

從地區來看,由於消費者對疤痕治療選擇的認知不斷提高以及美容手術越來越受歡迎,歐洲疤痕治療行業規模預計在 2024 年至 2032 年間將以 9.7% 的複合年成長率成長。該地區外科手術和創傷病例的盛行率增加。雷射療法和矽膠片等疤痕治療技術和產品的重大發展正在提供更有效的解決方案。有利的報銷政策和醫療基礎設施的存在也推動了區域市場的發展。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 皮膚病和創傷的發生率增加
      • 對美學外觀的意識和關注不斷提高
      • 疤痕治療技術的進步
      • 越來越多採用微創手術
    • 產業陷阱與挑戰
      • 治療費用高
      • 不良反應的風險
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 外用產品
    • 乳霜
    • 凝膠
    • 矽膠片
    • 其他局部產品
  • 雷射產品
    • 二氧化碳雷射
    • 脈衝染色雷射
    • 其他雷射產品
  • 注射劑
  • 其他產品

第 6 章:市場估計與預測:按類型,2018 - 2032

  • 主要趨勢
  • 萎縮性疤痕
  • 肥厚性疤痕和蟹足腫
  • 攣縮疤痕
  • 妊娠紋

第 7 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 診所
  • 零售藥局
  • 醫療水療
  • 其他最終用戶

第 8 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章:公司簡介

  • CCA Industries, Inc.
  • Clayton, Dubilier & Rice, LLC
  • Lumenis Be Ltd.
  • McKesson Corporation
  • Merz Pharma GmbH & Co. KGaA
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • SMITH & NEPHEW plc
  • Sonoma Pharmaceuticals, Inc.
  • Suneva Medical
簡介目錄
Product Code: 8467

Scar Treatment Market size is projected to expand at over 9.6% CAGR from 2024 to 2032, led by the rising incidence of burns, surgeries, and trauma cases. Strong advancements in technology, like laser therapy and silicone gel sheets are offering more effective and minimally invasive treatment options, subsequently accelerating the appeal of scar treatment solutions.

The increasing awareness about the availability of scar treatment products and procedures among consumers is pushing the preference for several treatment techniques due to the growing emphasis on aesthetics and the desire for flawless skin. The rollout of favorable reimbursement policies and healthcare infrastructure developments is also driving the adoption of scar treatment therapies

The hefty R&D investments in cosmetic sector are further promoting the development of new formulations, adding to the market growth. For instance, in August 2023, Topicals, a skincare brand, introduced its Sealed Active Scar Primer. This product fills acne scars before makeup application and enhances skin texture gradually.

The scar treatment industry is bifurcated into product, type, end-use, and region.

In terms of product, the market size from the laser products segment is estimated to record 9.6% CAGR from 2024 to 2032. Laser therapy offers precise and targeted treatment for various types of scars, including acne scars and surgical scars. The evolution in laser technology, such as fractional laser systems is enhancing treatment efficacy and minimizing downtime. The increasing consumer preference for non-invasive and minimally painful scar treatment options will also fuel the demand for laser products.

Based on type, the scar treatment market from the stretch marks segment is anticipated to expand at 9.2% growth rate from 2024 to 2032. This is owing to rising episodes of pregnancy, rapid weight gain or loss, and puberty. The increasing availability of topical creams, oils, and laser therapies specifically designed for stretch marks is accelerating the product penetration in addition to the growing awareness and acceptance of stretch mark treatments.

Regionally, the Europe scar treatment industry size is predicted to grow at 9.7% CAGR between 2024 and 2032, led by the increasing awareness about scar treatment options and rising popularity of aesthetic procedures among consumers. The prevalence of surgical procedures and trauma cases has grown across the region. Significant developments in scar treatment technologies and products, like laser therapy and silicone gel sheets are offering more effective solutions. The presence of favorable reimbursement policies and healthcare infrastructure are also driving the regional market progression.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of skin disorders and trauma
      • 3.2.1.2 Rising awareness and concern for aesthetic appearance
      • 3.2.1.3 Advancements in scar treatment technologies
      • 3.2.1.4 Increasing adoption of minimally invasive procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of treatment
      • 3.2.2.2 Risk of adverse effects
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Topical products
    • 5.2.1 Creams
    • 5.2.2 Gels
    • 5.2.3 Silicon sheets
    • 5.2.4 Other topical products
  • 5.3 Laser products
    • 5.3.1 CO2 laser
    • 5.3.2 Pulse-dyed laser
    • 5.3.3 Other laser products
  • 5.4 Injectables
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Atrophic scars
  • 6.3 Hypertrophic and keloid scars
  • 6.4 Contracture scars
  • 6.5 Stretch marks

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Retail pharmacies
  • 7.5 Medical spa
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Mexico
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 CCA Industries, Inc.
  • 9.2 Clayton, Dubilier & Rice, LLC
  • 9.3 Lumenis Be Ltd.
  • 9.4 McKesson Corporation
  • 9.5 Merz Pharma GmbH & Co. KGaA
  • 9.6 Newmedical Technology Inc.
  • 9.7 Perrigo Company plc
  • 9.8 SMITH & NEPHEW plc
  • 9.9 Sonoma Pharmaceuticals, Inc.
  • 9.10 Suneva Medical